Zobrazeno 1 - 10
of 1 166
pro vyhledávání: '"Nail psoriasis"'
Publikováno v:
JAAD International, Vol 16, Iss , Pp 105-111 (2024)
Background: Nail psoriasis remains a challenging condition with limited satisfaction from current treatments. An increasing number of neuropeptides were reported in psoriatic tissue. Objective: To compare the efficacy of botulinum toxin A (BoNT-A) in
Externí odkaz:
https://doaj.org/article/3ea8bd290ca34bf98d461ee05a19ef03
Autor:
Alessia Pacifico, Matilde Iorizzo, Marcel Pasch, Khalaf Kridin, Massimo Del Fabbro, Santo R. Mercuri, Lorenzo Peluso, Giovanni Damiani
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1161-1172 (2024)
Abstract Introduction Since during the COVID-19 pandemic nail psoriasis was evaluated exclusively with teledermatology, dermatologists started to face the difficulty in rating it concurrent with other onycopathies (i.e., onychotillomania and onychoph
Externí odkaz:
https://doaj.org/article/355677dd83424c3d8dfe00d52f7c4e19
Autor:
April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, Willie I. Visser, Natalie Haustrup, Bruce W. Konicek, Zbigniew Kadziola, Mercedes Nunez, Alan Brnabic, Christopher Schuster
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Despite the abundance of data concerning biologic treatments for patients with psoriasis, clinicians are often challenged with discerning the optimal treatment for each patient. To inform this selection, this study explored whether a patient’s base
Externí odkaz:
https://doaj.org/article/d5fdfe1fe6a64d17866ff3ddbaaf263a
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introducion: Psoriasis is a chronic inflammatory skin disease that can affect many parts of the body. Psoriatic involvement of the nail bed or nail matrix results in nail psoriasis that is common. Patients with psoriatic nails have impaired quality o
Externí odkaz:
https://doaj.org/article/872ef155b47946d984de373edd10e168
Autor:
Alexander Egeberg, Lars Erik Kristensen, Luis Puig, Phoebe Rich, Saxon D. Smith, Alyssa Garrelts, Kyoungah See, Thorsten Holzkaemper, Konstantinos Fotiou, Christopher Schuster
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Available network meta-analyses (NMAs) comparing the efficacy of biologics in nail psoriasis (NP) have not included recently approved biologics such as bimekizumab nor have they provided comparisons up to 1 year. Objective We conducted two
Externí odkaz:
https://doaj.org/article/5362c29498f147efbcd364accd7a6767
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2859-2868 (2023)
Abstract Introduction The aim of this study was to evaluate guselkumab efficacy on regional psoriasis in a subset of psoriasis patients with a self-reported psoriatic arthritis (PsA) diagnosis. Methods In the phase 3 VOYAGE-1 and -2 studies, at week
Externí odkaz:
https://doaj.org/article/5a5553774912446e94efd1f6ff6c66ad
Autor:
William Tillett, Alexander Egeberg, Enikö Sonkoly, Patricia Gorecki, Anna Tjärnlund, Jozefien Buyze, Sven Wegner, Dennis McGonagle
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background Nail psoriasis is a common, physiologically, and psychologically disruptive, and yet often under-treated manifestation of psoriasis. The objectives of this analysis were to investigate the trajectory of nail psoriasis, a risk fact
Externí odkaz:
https://doaj.org/article/1656e3c7c23f4285b1babbaa95118c66
Autor:
Bruce W. Kirkham, Alexander Egeberg, Frank Behrens, Andreas Pinter, Joseph F. Merola, Thorsten Holzkämper, Gaia Gallo, Khai Jing Ng, Rebecca Bolce, Christopher Schuster, Peter Nash, Luis Puig
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1127-1146 (2023)
Abstract Nail psoriasis is a difficult-to-treat manifestation of psoriatic disease affecting up to 80% of patients with psoriatic arthritis (PsA) and 40–60% of patients with plaque psoriasis (PsO). Ixekizumab (IXE), a high-affinity monoclonal antib
Externí odkaz:
https://doaj.org/article/4c9392c1257a45e0b15c5bcafb3f3df9
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 1899-1932 (2023)
Teresa Battista, Massimiliano Scalvenzi,* Fabrizio Martora,* Luca Potestio, Matteo Megna Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors contributed equall
Externí odkaz:
https://doaj.org/article/a6886c1f6eeb4e008325406a39f62340
Publikováno v:
Pifu-xingbing zhenliaoxue zazhi, Vol 30, Iss 2, Pp 131-138 (2023)
Objective To assess the clinical efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis. Methods Ninety-one patients with nail psoriasis from our hospital were randomly divided into cyclosporin group (30 cas
Externí odkaz:
https://doaj.org/article/5da8e63ae8ce4715b523dabf586f17e0